When should an adult patient receive an MMR (measles‑mumps‑rubella) booster vaccine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

MMR Booster for Adults

Adults born in 1957 or later need at least one dose of MMR vaccine, with a second dose (booster) specifically required for healthcare workers, students in postsecondary educational institutions, and international travelers. 1, 2

Birth Year Determines Baseline Requirements

  • Born before 1957: Generally considered immune to measles and mumps without vaccination; however, healthcare facilities should consider vaccinating unvaccinated personnel born before 1957 who lack laboratory evidence of immunity with 2 doses of MMR 1
  • Born in 1957 or later: Require documentation of at least 1 dose unless they have laboratory evidence of immunity or medical contraindication 1, 2

Who Needs a Second Dose (Booster)

A routine second MMR dose, administered minimum 28 days after the first dose, is specifically recommended for adults who: 1, 2

  • Work in healthcare facilities
  • Are students in postsecondary educational institutions (colleges, universities)
  • Plan to travel internationally

Additional Booster Indications

Two doses are also required for adults who: 1

  • Received inactivated (killed) measles vaccine or measles vaccine of unknown type from 1963-1967
  • Were vaccinated before 1979 with killed mumps vaccine or mumps vaccine of unknown type and work in healthcare
  • Have been recently exposed to measles or are in an outbreak setting
  • Live in a community experiencing a mumps outbreak and are in an affected age group

Special Considerations for Women

For rubella immunity specifically: 1, 2

  • All women of childbearing age, regardless of birth year, should have rubella immunity determined
  • If no evidence of immunity and not pregnant: vaccinate immediately
  • If pregnant without evidence of immunity: administer MMR upon completion or termination of pregnancy before hospital discharge

What Counts as Evidence of Immunity

Acceptable evidence includes: 2, 3

  • Documentation of 2 appropriately spaced MMR doses (first dose on or after first birthday)
  • Laboratory evidence of immunity to all three diseases
  • Laboratory confirmation of disease (provider-diagnosed disease is NOT acceptable for measles, mumps, or rubella) 2, 3

Critical Pitfall

Do not rely on provider-diagnosed disease as evidence of immunity—this was removed from acceptable criteria in 2012 for measles and mumps, and has never been acceptable for rubella 2, 3. Only laboratory-confirmed disease or serologic evidence of immunity counts.

If Serologic Testing Shows No Immunity After 2 Doses

Adults who received 2 documented MMR doses but show negative or equivocal titers do not routinely need additional doses 4. The 2-dose series provides adequate protection even when antibody titers are low or undetectable, as cellular immunity persists. Additional doses beyond the recommended 2-dose series are not routinely indicated outside of outbreak settings 4, 5.

Timing Between Doses

The minimum interval between MMR doses is 28 days 1, 2. There is no maximum interval—if the series is interrupted, continue where you left off without restarting.

References

Guideline

recommended adult immunization schedule: united states, 2012.

Annals of Internal Medicine, 2012

Guideline

recommended adult immunization schedule: united states, 2013*.

Annals of Internal Medicine, 2013

Research

Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 2013

Research

Are Boosters Necessary If Adult Patients Do Not Achieve Seroconversion After 2 Doses of the MMR Vaccine?

Journal of the American Board of Family Medicine : JABFM, 2023

Research

Adverse Events Among Young Adults Following a Third Dose of Measles-Mumps-Rubella Vaccine.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.